Welcome to our dedicated page for American Fusion news (Ticker: AMFN), a resource for investors and traders seeking the latest updates and insights on American Fusion stock.
American Fusion Inc. reports company developments tied to its Texatron fusion energy platform, including pre-production assembly readiness, component integration, diagnostic and testing support, and related working-capital needs. News also covers corporate actions involving the company's authorized-share structure, common-share base, financing arrangements, governance updates, and operating results.
American Fusion news also includes activity from its Government Procurement Services segment, which is positioned separately from the company's core fusion development activities. That coverage centers on government and institutional procurement work, source-of-supply vendor activity, and the company's broader public-company transition under the AMFN symbol.
American Fusion (OTC: AMFN) announced that CTO Dr. John E. Brandenburg will present its proprietary Texatron™ Fusion Engine™ technology at a scientific conference at Fermi National Accelerator Laboratory (Fermilab) in Batavia, Illinois, on the afternoon of Thursday, July 23, 2026.
Executives Michael G. Smith and Independent Director Fabrice David will attend, supporting technical and strategic discussions. The talk will cover Texatron’s compact pulsed-fusion architecture, confinement concepts, planned helium‑3/deuterium fuel pathway, expanding IP portfolio, and staged testing program with calibrated diagnostics and independent evaluation.
American Fusion (OTC: AMFN) announced its placement in a NetworkNewsWire editorial highlighting its compact fusion technology. Through subsidiary Kepler Fusion, the company is developing the Texatron, a truck-deployable, aneutronic Fusion Engine capable of delivering approximately 0.5 MW to 100+ MW of clean power.
The technology aims to reduce fuel supply-chain vulnerabilities for military and support high-density, reliable power in civilian sectors such as construction, desalination, space exploration and telecommunications.
American Fusion (OTC: AMFN) has begun operations at a new temporary North Texas engineering facility while its permanent integrated engineering, assembly and laboratory headquarters nears completion. The company is preparing Texatron™ Fusion Engine™ tests of 500 kW and 5 MW systems and has filed eighteen new U.S. patent applications covering multiple Texatron™ platform designs and subsystems. Management targets additional Texatron™ testing in July–August 2026, subject to facility readiness, agreements, and approvals, as it progresses toward commercially viable compact fusion energy systems.
American Fusion (OTC: AMFN) highlighted its inclusion in a NetworkNewsWire editorial on U.S. energy vulnerability and compact fusion. Through subsidiary Kepler Fusion, it is developing the Texatron, a compact, aneutronic, truck-deployable fusion engine targeting 0.5 MW to 100+ MW of clean power.
The technology aims to provide on-site, high-density energy for military and critical civilian sectors such as construction, desalination, space exploration and telecommunications.
American Fusion (OTC: AMFN), a fusion energy technology company, has deployed PubcoZone, an AI powered investor communications platform. The system monitors online discussions, detects misinformation, and helps draft filing-cited responses while keeping communications compliant with Regulation FD.
According to American Fusion, it does not expect this adoption alone to materially affect its financial condition or results.
American Fusion (OTC: AMFN) is relocating its headquarters from Midland to the Fort Worth, North Texas area in a two-phase move, consolidating engineering, fabrication, lab, and administrative operations under one roof.
The company reports progress toward a Texas Tech testing agreement and has filed seven new U.S. patent applications for its Texatron™ Fusion Engine™ platform.
American Fusion (OTC:AMFN) finalized a comprehensive testing protocol for its 5MW Pre-Production Texatron™ Fusion Engine™. The framework covers plasma density and temperature, neutron monitoring, spectroscopy, electrical power measurements, and strict calibration.
The company plans independent scientific observation, public testing videos, third-party reporting, and continues expanding its Texatron™ patent portfolio while preparing for commercial validation.
American Fusion (OTC: AMFN) reported outcomes from CTO Dr. John Brandenburg’s June 22, 2026 Texatron™ Fusion Engine™ presentation at IEEE ICOPS 2026, highlighting strong scientific engagement.
The company is advancing discussions with Texas Tech on using an NRC- and DSHS-approved testing facility, evaluating next-generation FT-ICR diagnostics, and has transported its 5MW Pre-Production Texatron™ Fusion Engine™ to the Fort Worth area for installation and commissioning ahead of future testing.
American Fusion (OTC:AMFN) reported arrival of its team in the Midland-Odessa region to accept delivery of a 5MW Pre-Production Texatron™ Fusion Engine™. The system will be moved to the Dallas-Fort Worth area for installation, commissioning, and integrated testing.
The 5MW platform follows nine prototype generations and is expected to be the main testbed for aneutronic fusion development. American Fusion has sufficient Deuterium and Helium-3 for anticipated tests through 2026 and is exploring future 10MW and 20MW systems, while expanding IP and regulatory initiatives.
American Fusion (OTC: AMFN) appointed physicist Dr. Robert V. Duncan as Independent Scientific and Strategic Advisor. Duncan is President’s Distinguished Chair in Physics at Texas Tech University and has held senior roles at Sandia, Los Alamos-related programs, and major research universities.
According to American Fusion, he will advise on development and testing of the Texatron Fusion Engine, intellectual property strategy, commercialization planning, government and national laboratory engagement, corporate governance, and long-term fusion deployment strategies, reinforcing the company’s focus on rigorous scientific development.